HIV-1 drug resistance surveillance using dried whole blood spots

Antiviral Therapy

Volumn 12, Issue 1, 2007, Pages 107-113

  Bertagnolio, Silvia ^a   Soto Ramirez, Luis ^b   Pilon, Richard ^c   Rodriguez, Roberto ^b   Viveros, Monica ^b   Fuentes, Luis ^b   Harrigan, P Richard ^d   Mo, Theresa ^d   Sutherland, Don ^a   Sandstrom, Paul ^c  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; RNA DIRECTED DNA POLYMERASE;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SURVEILLANCE PROGRAM; FEMALE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NUCLEIC ACID AMPLIFICATION; PHYLOGENY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; BLOOD SPECIMEN COLLECTION; DRUG RESISTANCE, VIRAL; FEASIBILITY STUDIES; FEMALE; GENOTYPE; HIV INFECTIONS; HIV PROTEASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MALE; MEXICO; MIDDLE AGED; MUTATION; PHYLOGENY; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 33847345927     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Cassol S, Weniger BG, Babu PG, et al. Detection of HIV-type env subtype A, B, C and E in Asia using dried blood spots: a new surveillance tool for molecular epidemiology. AIDS Res Hum Retroviruses 1996; 12:1435-1441.
2. Mwaba P, Cassol S, Nunn A, et al. Whole blood versus plasma spots for measurement of HIV-1 viral load in HIV-infected African patients. Lancet 2003; 362:2067-2068.
3. Cassol S, Gill MJ, Pilon R, et al. Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paper. J Clin Microbiol 1997; 35:2795-2801.
4. Brambilla D, Jennings C, Aldrovandi G, et al. Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability. J Clin Microbiol 2003; 41:1888-1893.
5. + lymphocyte count in HIV-1 infected patients. Lancet 2003; 362:1459-1460.
6. Boom R, Sol CJ, Salimans MM, et al. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990; 28:495-503.
7. Alexander CS, Dong W, Schechter MT, et al. Prevalence of primary HIV drug resistance among seroconverters during an explosive outbreak of HIV infection among injecting drug users. AIDS 1999; 13:981-985.
8. Kumar S, Tamura K, Nei. M. MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform 2004; 5:150-163
9. Johnson AV, Brun-Vezinet F, Clotet B, et al. Update of the Drug Resistance Mutations in HIV-1: 2005. Top HIV Med 2005; 13:51-57.
10. O'Shea S, Mullen J, Corbett K, et al. Use of dried whole blood spots for quantitation of HIV-1 RNA. AIDS 1999; 13:630-631
11. Ghosn J, Viard JP, Katlama C, et al. Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-invected men. AIDS 2004; 18:447-457
12. Shafer RW, Hertogs K, Zolopa AR, et al. High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients. J Clin Microbiol 2001; 39:1522-1529.
13. Galli RA, Sattha B, Wynhoven B, et al. Sources and magnitude of intralaboratory variability in a sequence-based genotypic assay for human immunodeficiency virus type 1 drug resistance. J Clin Microbiol 2003; 41:2900-2907.
14. Plantier JC, Dachraoui R, Lemee V, et al. HIV-1 resistance genotyping on dried serum spots. AIDS 2005; 19:391-397.